Statement Of Cash Flows [Abstract]
| Concept |
2024-01-01 to 2024-12-31 |
2023-01-01 to 2023-12-31 |
|---|---|---|
| Statement of cash flows [abstract] | ||
| Cash flows from (used in) operating activities [abstract] | ||
| Adjustments for finance income (cost) |
162,000,000
EUR
|
97,000,000
EUR
|
| Cash flows from (used in) operations before changes in working capital |
985,000,000
EUR
|
600,000,000
EUR
|
| Adjustments for decrease (increase) in trade and other receivables |
166,000,000
EUR
|
823,000,000
EUR
|
| Adjustments for increase (decrease) in trade and other payables |
177,000,000
EUR
|
887,000,000
EUR
|
| Adjustments for increase (decrease) in employee benefit liabilities |
3,000,000
EUR
|
7,000,000
EUR
|
| Adjustments for amortisation expense |
126,000,000
EUR
|
96,000,000
EUR
|
| Adjustments for depreciation expense |
384,000,000
EUR
|
348,000,000
EUR
|
| Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss, trade and other receivables |
8,000,000
EUR
|
13,000,000
EUR
|
| Adjustments for gains (losses) on change in fair value less costs to sell, biological assets |
3,000,000
EUR
|
11,000,000
EUR
|
| Adjustments for undistributed profits of investments accounted for using equity method |
32,000,000
EUR
|
52,000,000
EUR
|
| Income taxes paid, classified as operating activities |
68,000,000
EUR
|
42,000,000
EUR
|
| Cash flows from (used in) investing activities [abstract] | ||
| Dividends received from investments accounted for using equity method, classified as investing activities |
68,000,000
EUR
|
21,000,000
EUR
|
| Cash flows from (used in) financing activities [abstract] | ||
| Payments for debt issue costs |
-
EUR
|
1,000,000
EUR
|